Repros Therapeutics Inc (NASDAQ:RPRX) - Overview

Stock Report

Repros Therapeutics Inc RPRX

Last Price
$1.95

Day Change
0.18|10.17%

As of 05/12/2016
16:00:00 EST | USD
Minimum 15 Minutes Delay.

Last Close1.77
Day Range1.79 - 1.97
Mkt Cap49.58Mil
52-Wk Range0.80 - 3.48
Yield %-
ISINUS76028H2094
Volume474,098
P/E-2.41
P/S1,000.00
P/CF-2.75

Share Price

Financials
201320142015
More ...
Income Statement
Revenue0.010.010.01
Operating Income-27.72-32.54-29.19
Net Income-27.72-32.54-29.19
Basic EPS-1.33-1.39-1.20
Avg. Diluted Shares Outstanding212324
Balance Sheet
Current Assets76.0046.9121.48
Non Current Assets2.980.030.01
Total Assets78.9846.9421.49
Current Liabilities3.552.922.92
Total Liabilities3.552.922.92
Total Equity75.4344.0218.57
Cash Flow
Operating Cash Flow-24.45-29.33-25.33
Capital Expenditure-0.91--
Free Cash Flow-25.36--

In millions, except "Basic EPS". Currency is USD.

Company Profile

Repros Therapeutics Inc is a development stage biopharmaceutical company. The Company is engaged in the development of new drugs to treat hormonal and reproductive system disorders.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Growth

Fiscal Year Ends

December

Employees

24
Key Stats
More ...
Price/Earning TTM-2.19
Price/Book5.38
Price/Sales TTM1,106.25
Rev Growth (3 year avg)54.20
EPS Growth (3 year avg)-
Operating Margin % TTM-265,381.82
Net Margin % TTM-265,381.82
ROE TTM-93.29
Debt/Equity-
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2016 Morningstar. All rights reserved.